Health-care companies rose sharply after President Trump signed an executive order designed to lower what Americans pay for prescription drugs that offered pharmaceutical companies room for ...

Key TakeawaysGlobal pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as ...

Trump’s comments of "cutting out the middlemen" also weighed on shares of companies that own pharmacy benefit managers.

Merck & Co., Inc. (MRK) is currently at $79.17, up $3.20 or 4.21% --On pace for largest percent increase since March 27, 2024, when it rose 4.96% --Down 40.46% from its all-time closing high of ...

Halozyme Therapeutics posts strong Q1 2025 earnings with 35% revenue growth, robust pipeline, and rising royalties.

The post shared by Ark’s multiomics analyst, Nemo M Despot, underscored that “AI is powering a self-reinforcing loop that ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...